Targeting Myc in pediatric malignancies of the central and peripheral nervous system.

Abstract

Myc family genes are often deregulated in embryonal tumors of childhood including medulloblastoma and neuroblastoma and are frequently associated with aggressive, poorly differentiated tumors. The Myc protein is a transcription factor that regulates a variety of cellular processes including cell growth and proliferation, cell cycle progression, differentiation, apoptosis, and cell motility. Potential strategies that either inhibit the proliferation-promoting effect of Myc and/or activate its pro-apoptotic function are presently being explored. In this review, we will give an overview of Myc activation in embryonal tumors and discuss current strategies aimed at targeting Myc for cancer treatment.

Statistics

010020020102011201220132014201520162017
Citations per Year

226 Citations

Semantic Scholar estimates that this publication has 226 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Grotzer2009TargetingMI, title={Targeting Myc in pediatric malignancies of the central and peripheral nervous system.}, author={Michael Andreas Grotzer and Deborah Castelletti and Giulio Fiaschetti and Tarek Al Shalaby and Alexandre Arcaro}, journal={Current cancer drug targets}, year={2009}, volume={9 2}, pages={176-88} }